A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00629876
Recruitment Status : Terminated (Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology indications.)
First Posted : March 6, 2008
Last Update Posted : December 1, 2011
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2008
  Actual Study Completion Date : June 2008